Before starting semaglutide, you should consider if its the right fit for your health needs and medical history
Intestinal Incretins and the Regulation of Bone Physiology
Who Retatrutide Is For and Who Should Avoid It Retatrutide is currently studied in adults with obesity, adults with type 2 diabetes, and adults with weight-related conditions like knee osteoarthritis, sleep apnea, and metabolic dysfunction-associated steatotic liver disease (MASLD)
This is not an assessment of their clinical effectiveness, safety, or superiority
Retatrutide , a triple agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, is in advanced clinical trials